These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 15899649)

  • 1. Antibody titer against malondialdehyde-modified LDL compares with HDL cholesterol concentration in identifying angiographically verified coronary artery disease. Comparison of tests by ROC analysis.
    Rontu R; Metso S; Jaakkola O; Nikkilä M; Jokela H; Lehtimäki T
    Clin Chem Lab Med; 2005; 43(4):357-60. PubMed ID: 15899649
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Autoantibodies to malondialdehyde-modified low-density lipoprotein in patients with angiographically confirmed coronary artery disease.
    McDowell A; Young IS; Wisdom GB
    J Pharm Pharmacol; 2002 Dec; 54(12):1651-7. PubMed ID: 12542895
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Autoantibody against, malondialdehyde-modified low density lipoprotein in patients with non-diabetic unstable angina: a potential role in immunologic reaction of plaque instability.
    Kwon KH; Kwon HM; Hong BK; Kim DS; Lee JY; Ryu SK; Park BE; Park HY; Kim JH; Yoon YW; Cho SY; Kim HS
    Yonsei Med J; 2002 Apr; 43(2):203-10. PubMed ID: 11971214
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased circulating malondialdehyde-modified LDL levels in patients with coronary artery diseases and their association with peak sizes of LDL particles.
    Tanaga K; Bujo H; Inoue M; Mikami K; Kotani K; Takahashi K; Kanno T; Saito Y
    Arterioscler Thromb Vasc Biol; 2002 Apr; 22(4):662-6. PubMed ID: 11950707
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Improved identification of patients with coronary artery disease by the use of new lipid and lipoprotein biomarkers.
    Johnston N; Jernberg T; Lagerqvist B; Siegbahn A; Wallentin L
    Am J Cardiol; 2006 Mar; 97(5):640-5. PubMed ID: 16490429
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum high-density lipoprotein-cholesterol levels modify the association between plasma levels of oxidatively modified low-density lipoprotein and coronary artery disease in men.
    Zhang B; Bai H; Liu R; Kumagai K; Itabe H; Takano T; Saku K
    Metabolism; 2004 Apr; 53(4):423-9. PubMed ID: 15045686
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HMG-CoA reductase inhibitor (Statin) therapy and coronary atherosclerosis in Japanese subjects: role of high-density lipoprotein cholesterol.
    Tani S; Nagao K; Hirayama A
    Am J Cardiovasc Drugs; 2011 Dec; 11(6):411-7. PubMed ID: 22149320
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The associations among thoracic aortic atherosclerosis, coronary atherosclerosis and the function of high density lipoprotein.
    Takao M; Zhang B; Fan P; Nomoto J; Saku K
    Atherosclerosis; 2001 Dec; 159(2):407-16. PubMed ID: 11730821
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Optimal cutoff value of high-density lipoprotein cholesterol for predicting coronary artery disease in Taiwanese population.
    Huang YC; Ho CC; Lin PT; Lee BJ; Lai CH; Liaw YP
    Nutr Res; 2010 Jan; 30(1):21-6. PubMed ID: 20116656
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasma lipoprotein particle concentrations in postmenopausal women with unstable coronary artery disease. Analysis of diagnostic accuracy using receiver operating characteristics.
    Nielsen NE; Olsson AG; Swahn E
    J Intern Med; 2000 Jan; 247(1):43-52. PubMed ID: 10672130
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Is evaluation of non-HDL-C better than calculated LDL-C in CAD patients? MMIMSR experiences.
    Kathariya G; Aggarwal J; Garg P; Singh S; Manzoor S
    Indian Heart J; 2020; 72(3):189-191. PubMed ID: 32768019
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The oxidation ratio of LDL: a predictor for coronary artery disease.
    Huang H; Mai W; Liu D; Hao Y; Tao J; Dong Y
    Dis Markers; 2008; 24(6):341-9. PubMed ID: 18688083
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Investigation of MDA-LDL (malondialdehyde-modified low-density lipoprotein) as a prognostic marker for coronary artery disease in patients with type 2 diabetes mellitus.
    Kotani K; Tashiro J; Yamazaki K; Nakamura Y; Miyazaki A; Bujo H; Saito Y; Kanno T; Maekawa M
    Clin Chim Acta; 2015 Oct; 450():145-50. PubMed ID: 26265234
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antibodies to oxidized low-density lipoproteins and angiographically assessed coronary artery disease in white patients.
    Rossi GP; Cesari M; De Toni R; Zanchetta M; Maiolino G; Pedon L; Ganzaroli C; Maiolino P; Pessina AC
    Circulation; 2003 Nov; 108(20):2467-72. PubMed ID: 14581399
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Malondialdehyde-modified LDL as a marker of acute coronary syndromes.
    Holvoet P; Collen D; Van de Werf F
    JAMA; 1999 May; 281(18):1718-21. PubMed ID: 10328072
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Component analysis of HPLC profiles of unique lipoprotein subclass cholesterols for detection of coronary artery disease.
    Okazaki M; Usui S; Fukui A; Kubota I; Tomoike H
    Clin Chem; 2006 Nov; 52(11):2049-53. PubMed ID: 16990425
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High-density lipoprotein cholesterol, C-reactive protein, and prevalence and severity of coronary artery disease in 5641 consecutive patients undergoing coronary angiography.
    Alber HF; Wanitschek MM; de Waha S; Ladurner A; Suessenbacher A; Dörler J; Dichtl W; Frick M; Ulmer H; Pachinger O; Weidinger F
    Eur J Clin Invest; 2008 Jun; 38(6):372-80. PubMed ID: 18489399
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Significance of serum high-density lipoprotein cholesterol levels for diagnosis of coronary stenosis as determined by MDCT in patients with suspected coronary artery disease.
    Shiga Y; Miura S; Mitsutake R; Kawamura A; Uehara Y; Saku K
    J Atheroscler Thromb; 2010 Aug; 17(8):870-8. PubMed ID: 20467190
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Significance of the percentage of cholesterol efflux capacity and total cholesterol efflux capacity in patients with or without coronary artery disease.
    Norimatsu K; Kuwano T; Miura SI; Shimizu T; Shiga Y; Suematsu Y; Miyase Y; Adachi S; Nakamura A; Imaizumi S; Iwata A; Nishikawa H; Uehara Y; Saku K
    Heart Vessels; 2017 Jan; 32(1):30-38. PubMed ID: 27106918
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasma levels of antibodies against oxidized LDL are inherited but not associated with HDL-cholesterol level in families with early coronary heart disease.
    Paavola T; Kangas-Kontio T; Salonurmi T; Kuusisto S; Huusko T; Savolainen MJ; Kakko S
    Atherosclerosis; 2012 Sep; 224(1):123-8. PubMed ID: 22818623
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.